Smruthi Organics Ltd
BSE:540686
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IN |
|
Smruthi Organics Ltd
BSE:540686
|
1.3B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
298.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
309B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.1B USD |
Loading...
|
Market Distribution
| Min | -3 052.3% |
| 30th Percentile | 26.9% |
| Median | 39% |
| 70th Percentile | 53.3% |
| Max | 8 269.1% |
Other Profitability Ratios
Smruthi Organics Ltd
Glance View
Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. The company is headquartered in Solapur, Maharashtra. The company went IPO on 2017-08-29. The Company’s operating segments include Formulation. The firm's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The firm has 2 manufacturing facilities in Solapur, Maharashtra. with a combined reactor capacity of over 320 kiloliters. The firm manufactures API from kilo to metric ton scale. The firm serves pharmaceutical companies in India and across the globe. The firm caters to both domestic and international markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Smruthi Organics Ltd is 48.7%, which is above its 3-year median of 40.1%.
Over the last 3 years, Smruthi Organics Ltd’s Gross Margin has increased from 36.5% to 48.7%. During this period, it reached a low of 26.8% on Mar 31, 2023 and a high of 48.7% on Sep 30, 2025.
